A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (P302) ASSESSING THE EFFICACY AND SAFETY OF SPN-812 (EXTENDED-RELEASE VILOXAZINE) 200 AND 400MG FOR THE TREATMENT OF ADHD IN ADOLESCENTS

Authors
Category Primary study
JournalJOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
Year 2019
This article has no abstract
Epistemonikos ID: 836b93f21e25479039c1a044197a8dff7605c1a3
First added on: Feb 11, 2025